Diabetic Foot Ulcer Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight
(Albany, US) DelveInsight has launched a new report on "Diabetic foot ulcers Market Insights, Epidemiology, and Market Forecast-2030".
DelveInsight's "Diabetic
foot ulcers Market Insights, Epidemiology, and Market Forecast -2030" report
delivers an in-depth understanding of the Diabetic foot ulcers, historical and
forecasted epidemiology as well as the Diabetic foot ulcers market trends in
the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and
Japan.
Some of the Facts:
·
The global diabetic
foot ulcer prevalence was 6.3%, which was higher in males than in
females.
·
North America had the highest Diabetic Foot
Ulcers prevalence, Oceania had the lowest and Diabetic Foot Ulcers prevalence
in Europe, and Africa were 5.1% and 7.2%, respectively.
·
10-30% of diabetic patients with a foot ulcer
will eventually progress to amputation. The prevalence of foot ulcers among
diabetic patients ranges from 2% to 12%.
·
Approximately 451 million adults worldwide have
diabetes, a figure projected to increase to 693 million by 2045 globally.
View Report: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
·
The report covers the descriptive overview of
Diabetic foot ulcers, explaining its causes, signs and symptoms,
pathophysiology, diagnosis and currently available therapies
·
Comprehensive insight has been provided into the
Diabetic
foot ulcers epidemiology and treatment in the 7MM
·
Additionally, an all-inclusive account of both
the current and emerging therapies for Diabetic foot ulcers are provided, along
with the assessment of new therapies, which will have an impact on the current
treatment landscape
·
A detailed review of Diabetic
foot ulcers market; historical and forecasted is included in the
report, covering drug outreach in the 7MM
·
The report provides an edge while developing
business strategies, by understanding trends shaping and driving the global
Diabetic foot ulcers market
"Over 55 million Europeans suffer from diabetes, and 8 million of
these patients are at risk of developing a diabetic foot ulcer."
Diabetic
foot ulcers is a
lesion of all layers of skin, necrosis, or gangrene that occurs in the sole of
the feet in diabetes mellitus (DM) patients, caused by: (1) causative factor
(peripheral neuropathy, high foot plantar pressure, and trauma); (2)
contributive factors (atherosclerosis and diabetes). Diabetic foot ulcers can
be followed by bacterial invasion resulting in infection and decay, can occur
in any part of the body especially in the distal part of the lower leg. The
sign and symptoms of Diabetic foot ulcers (DFU) includes, swelling,
discoloration, and warmth around the wound, foul-smelling discharge seeping
from the wound, Pain and firmness when the wound is touched and Call used or
thickened skin surrounding the ulcer.
According to Edmon, the diabetic foot ulcers are divided
into two groups, namely: Neuropathic ulcers (feet is warm, perfusion is still
good with pulsation still palpable, perspiration is reduced, skin dry and
cracked).
Neuroischemic ulcers (feet is colder, not palpable
pulsation, thin skin, smooth, and without hair, subcutaneous tissue atrophy,
intermittent claudication, and rest pain may not be present due to neuropathy).
View Report: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
Some of the Diabetic
foot ulcers Companies:
·
Origin
·
Microbion Corporation
·
Smith & Nephew
·
Venturis Therapeutics
·
And many others
Diabetic
foot ulcers Drugs
Covered:
·
Plasma-generated nitric oxide
·
MBN-101
·
Regranex Gel (becaplermin)
·
CVBT-141
·
And many others
View Report: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
1. Report Introduction
2. Diabetic Foot Ulcers Market Overview at a Glance
3. Diabetic Foot Ulcers Disease Background and Overview
4. Diabetic Foot Ulcers Epidemiology and Patient Population
5. Diabetic Foot Ulcers Country- Wise Epidemiology
5.1. United States
5.2. EU-5
5.2.1. Germany
5.2.2. France
5.2.3. Italy
5.2.4. Spain
5.2.5. United Kingdom
5.3. Japan
6. Diabetic Foot Ulcers Treatment & Medical Practices
7. Diabetic Foot Ulcers Marketed Drugs
7.1. Regranex Gel (becaplermin): Smith & Nephew
8. Diabetic Foot Ulcers Emerging Therapies
8.1. Key Cross Competition
8.2. Plasma-generated nitric oxide: Originww
8.3. MBN-101: Microbion Corporation
9. Diabetic Foot Ulcers Market Size
10. 7MM Diabetic Foot Ulcers Country-Wise Market Analysis
10.1. United States
10.2. Germany
10.3. France
10.4. Italy
10.5. Spain
10.6. United Kingdom
10.7. Japan
11. Diabetic Foot Ulcers Report Methodology
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight
Related Reports:
- Diabetic
Ketoacidosis Market
- Diabetic
retinopathy Epidemiology
- Diabetic
foot ulcers Epidemiology
- Diabetic
Gastroparesis Epidemiology
- Diabetic
Macular Edema Epidemiology
About DelveInsight
DelveInsight is a leading Life Science market research and
business consulting company recognised for its off-the-shelf syndicated market
research reports as well as customised solutions to firms in the healthcare
sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment